Skip to main content

Table 1 Assessment schedule

From: A multicenter double-blind randomized crossover study comparing the impact of dorsal subthalamic nucleus deep brain stimulation versus standard care on apathy in Parkinson’s disease: a study protocol

 

Pre-operative

Post-operative

Inclusion

Baseline

Visit 1 (+ 1 month)

Visit 2 (+ 2 months)

End of trial

SAS

X

 

X

X

X

X

 

MRI, DTI

X

      

CT scan

 

X

     

In- and exclusion criteria

  

X

    

MOCA

  

X

    

Baseline characteristics

   

X

   

MDS-UPDRS-III

X

  

X

X

X

 

PDQ-39

   

X

X

X

 

QUIP

X

  

X

X

X

 

LEDD

X

  

X

X

X

 

MADRS

X

  

X

X

X

 

AES-I*

   

X

X

X

 

SF-36*

   

X

X

X

 

Suspected arm

      

X

Preferred settings

      

X

  1. SAS Starkstein’s Apathy Scale, MOCA Montreal Cognitive Assessment, MDS-UPDRS-III Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale, motor part III, MADRS Montgomery-Åsberg Depression Rating Scale (MADRS), PDQ-39 39-item Parkinson’s disease questionnaire, QUIP Parkinson's Disease Impulsive-Compulsive Disorders Questionnaire, LEDD levodopa-equivalent daily dosage, AES-I Apathy Evaluation Scale, a second apathy scale rated by the informal caregiver if the patient has one. SF-36 Short-Form Health Survey. Suspected arm, patients will be asked to choose which arm they think they were randomized for. Preferred settings, patients will be asked to choose which of the settings they will continue with. *Although the timing for these questionnaires is the same as the visits for the patients, these questionnaires might be sent by regular mail to the informed caregiver
Back to article page

Trials

ISSN: 1745-6215